/PRNewswire/ Lucius Partners, LLC ("LP"), today announced the filing of two new patent applications to the USPTO by its portfolio company AerWave Medical,.
Share:
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) Laidlaw Venture Partners ( LVP ), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the successful closing of a $4 million Series A financing round for its portfolio company AerWave.
AerWave offers an interventional approach to treat Asthma, COPD and advanced lung disease, which addresses a significant unmet medical need. It is targeting the addressable COPD market made up of 4 million patients in the US, and the addressable Asthma market of 2.5 million patients in the US. The Company has broad intellectual property protection in place and a seasoned, experienced executive team with a track record of value creation.
Share:
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) Laidlaw Venture Partners ( LVP ), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the successful closing of a $4 million Series A financing round for its portfolio company AerWave.
AerWave offers an interventional approach to treat Asthma, COPD and advanced lung disease, which addresses a significant unmet medical need. It is targeting the addressable COPD market made up of 4 million patients in the US, and the addressable Asthma market of 2.5 million patients in the US. The Company has broad intellectual property protection in place and a seasoned, experienced executive team with a track record of value creation.